Pascal Michoux’s Post

View profile for Pascal Michoux, graphic

TEVA Vice President Global Head of Environment, Health, Safety and Sustainability

Teva is using AI to develop digital biomarkers for conditions including schizophrenia and neurodegenerative diseases and accelerate clinical trial processes to get medicines to patients faster. Meet the people who are developing some of the most advanced and potentially game-changing technologies in healthcare today: https://lnkd.in/dctxCTDD #AIinHealthcare #HealthTech #HealthcareInnovation

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics